Clinical Trials Browser

Cell- and Tissue-Based Therapy × Other hematologic neoplasm × Clear all

NCT04744116 2025-11-10

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT06849921 2025-02-27

Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors

Phase NA Active not recruiting

Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

NCT01947322 2017-08-29

NK

Phase 1/2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute